Investing
LRCX rocketed 21% in a week to $366, now trading above analyst consensus at a stretched 47x forward earnings.
China generates 34% of Lam’s revenue, and insiders turned net sellers across seven recent transactions, compounding valuation risk at current levels.
A pullback to $330 would compress the forward multiple toward 40x and restore the analyst consensus target as meaningful support.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Lam Research didn’t make the cut. Grab the names FREE today.
Sending You to Google News in 3
© MACRO PHOTO / iStock via Getty Images
At $366.81, Lam Research (NASDAQ:LRCX | LRCX Price Prediction) trades in a zone where valuation and momentum are in tension. The stock has rocketed 20.95% in the past week as softer rates and a fresh Fed posture reset risk appetite across semicap.
Lam designs deposition and etch tools for leading-edge logic, high-bandwidth memory, and 3D NAND. Q3 FY26 revenue hit $5.84 billion, up 23.76% year over year, with non-GAAP EPS of $1.47 against $1.3633 consensus. June-quarter guidance calls for $6.60 billion in revenue and $1.65 in EPS, a sequential acceleration the market did not anticipate three months ago.
Bulls see Lam as the cleanest way to own AI capex without paying for a chip designer’s product risk. Management’s upgraded $140 billion global wafer-fab equipment outlook arrives as customers transition to high-density 3D NAND stacks and advanced packaging, both deposition and etch intensive where Lam holds entrenched position.
Operating margin expanded to 35.0% from 33.9% sequentially, return on equity sits at 66.8%, and Barclays lifted its target to $335 from $275. CEO Tim Archer: “Lam delivered record revenue and EPS in the March quarter as AI-driven demand reshapes the semiconductor industry.”
Bears point to a forward P/E of roughly 47 and trailing P/E near 69, both above five-year group averages. Current price sits above the $323.38 analyst consensus target, and crowd-sourced pricing implies -1.02% drift.
Concentration risk compounds valuation concerns. China generated $1.99 billion, roughly 34% of last quarter’s revenue, exposing the franchise to export-control tightening. Insider activity turned net selling across seven recent transactions, and free cash flow fell 20.65% year over year despite the revenue beat.
The pause case rests on timing while the thesis remains intact. Fundamentals justify a premium multiple, but a stock that tripled in twelve months rarely offers clean entry at the highs. With shares $373.82 from their 52-week peak, asymmetry has flipped.
A technical reset tips the verdict. A pullback into the $330 zone restores reasonable risk/reward, while a break of the $285 fifty-day average forces reassessment of AI capex cadence itself.
Lam trades at $366.81 against $323.38 consensus target, implying modest downside if the average view holds. Among 36 covering analysts, distribution skews bullish:
Performance dwarfs the broader tape. LRCX is up 114.53% year to date and 303.12% over the past year, against the S&P 500’s 8.77% YTD and 22.86% one-year gains. Market cap sits at $458.7 billion.
At $366, Lam Research is a Hold. The bull thesis remains intact while the entry price has stretched. A 21% one-week move driven by macro relief rather than fresh fundamentals is the kind of squeeze that often retraces before extending. The case rests on the upgraded $140 billion WFE outlook and the 3D NAND plus advanced packaging transition, both compounding over years, not weeks. That favors a patient stance for those weighing entry.
The specific trigger is consolidation into the $330 zone, where the forward multiple compresses toward 40 and the analyst target reasserts as support. A break above $375 on confirmed June-quarter execution forces a different conversation, but chasing into the 52-week high with insiders distributing is a thin edge.
What invalidates patience is a fresh China headline or export-control easing that re-rates China revenue. What invalidates the bullish backstop is any softening of hyperscaler capex commentary into the next earnings cycle. Until then, the thesis can be tracked while the chart sets a clearer entry.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
Our top personal finance-related articles today. Your wallet will thank you later.
At $567.25, Applied Materials (NASDAQ:AMAT | AMAT Price Prediction) looks extended for fresh capital, with the setup improving meaningfully on…
At $1,646.54, SanDisk (NASDAQ:SNDK | SNDK Price Prediction) looks fully valued. The June rebound has pushed the stock into the…
JPMorgan analyst Harlan Sur raised his price target on Lam Research (NASDAQ:LRCX | LRCX Price Prediction) stock to $315 from…
NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) at $235.74 screens attractively under $250. President Trump’s China visit and growing signals that…
SpaceX (NASDAQ:SPCX) at $160.95 presents an interesting entry-point question on any macro-driven post-IPO consolidation at or below $140. With the…
Advanced Micro Devices (NASDAQ:AMD | AMD Price Prediction) at $420.99 screens as a compelling research setup. The stock pulled back…
Micron Technology (NASDAQ:MU | MU Price Prediction) at $949.28 is a Hold, with fresh capital better deployed on a pullback…
At $395.30, Google (NASDAQ:GOOG | GOOG Price Prediction) is a hold. The stock is pressed against its $397.28 52-week high…
Wells Fargo trimmed its price target on Meta Platforms (NASDAQ:META | META Price Prediction) to $765 from $856 while maintaining…
Buy, Hold, or Sell: Lam Research Rocketed 21% Off Its June Lows as a New Fed Begins. Is LRCX Worthwhile at $366? – 24/7 Wall St.
Leave a Comment
